Dr. Spiros A. Vlahopoulos is a Biologist at the Agia Sophia Children's Hospital and researcher of the NK University Research Institute of Maternal and Child Health and Precision Medicine, who earned a diploma in Biology in 1993 at the University of Cologne Genetics Department and a Ph.D. in Biology in 1999 at the University of Texas Medical Branch at Galveston. He conducted postdoctoral research at Baylor College of Medicine. His main areas of interest are regarding cellular signaling mechanisms elicited by homeostatic imbalance and developmental stimuli exemplified by anoikis, nuclear factor kappa B feedback networks, and interference between signals transduced by hormone receptors and inflammation-induced transactivators. A few key contributions relate to the mechanism of oxidant stress-induced regulation of gene expression by transcription factor NFKB, and to the elucidation of the mechanism of regulation of myogenesis by steroids. He is currently studying gene targets for the modulation of immune system interactions with other systems and host tissues. He became a member of FASEB (specifically of ASBMB) in 2004, and was elected as a full member of Sigma Xi in 2024.
Dr. Spiros A. Vlahopoulos is a Biologist at the Agia Sophia Children's Hospital and researcher of the NK University Research Institute of Maternal and Child Health and Precision Medicine, who earned a diploma in Biology in 1993 at the University of Cologne Genetics Department and a Ph.D. in Biology in 1999 at the University of Texas Medical Branch at Galveston. He conducted postdoctoral research at Baylor College of Medicine. His main areas of interest are regarding cellular signaling mechanisms elicited by homeostatic imbalance and developmental stimuli exemplified by anoikis, nuclear factor kappa B feedback networks, and interference between signals transduced by hormone receptors and inflammation-induced transactivators. A few key contributions relate to the mechanism of oxidant stress-induced regulation of gene expression by transcription factor NFKB, and to the elucidation of the mechanism of regulation of myogenesis by steroids. He is currently studying gene targets for the modulation of immune system interactions with other systems and host tissues. He became a member of FASEB (specifically of ASBMB) in 2004, and was elected as a full member of Sigma Xi in 2024.